Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis

Andrew Blauvelt; Melinda Gooderham; Christopher Em Griffiths; April W. Armstrong; Baojin Zhu; Russel Burge; Gaia Gallo; Jiaying Guo; Alyssa Garrelts; Mark Lebwohl

doi:10.1007/s13555-022-00690-5

Related publications

Article2020

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*

Andrew Blauvelt, C. Leonardi, Boni E. Elewski, Jeffrey Crowley, Lyn Guenther, Melinda Gooderham, Richard G. Langley, Ronald Vender, Andreas Pinter, Christopher Em Griffiths, Yayoi Tada, Hany Elmaraghy, Renata Gontijo Lima, Gaia Gallo, L. Renda, Russel Burge, S.Y. Park, Baojin Zhu, Kim Papp

Article2024

Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body Areas

Alice B. Gottlieb, April W. Armstrong, Andrew Blauvelt, Christopher Em Griffiths, Andreas Pinter, Melinda Gooderham, Mark Lomaga, Russel Burge, Bruce W. Konicek, Meghan Feely McDonald, Kyoungah See, Missy McKean-Matthews, Tomotaka Mabuchi

Article2010

Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial

Kristian Reich, Jean-Paul Ortonne, Urs Kerkmann, Yanxin Wang, J.‐H. Saurat, Kim Papp, Richard G. Langley, Christopher Em Griffiths

Article2022

Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure

Christopher Em Griffiths, Melinda Gooderham, Jean‐Frédéric Colombel, Tadashi Terui, Ana P. Accioly, Gaia Gallo, Danting Zhu, Andrew Blauvelt

Article2017

Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies

Christopher Em Griffiths, Maurizio Fava, Andrew H. Miller, James Russell, Susan Ball, Wen Xu, Nayan Acharya, Mark Hyman Rapaport